RE:RE:RE:RE:RE:RE:RE:RE:Future goals for HVT MMJ owns 57Million shares of HVT. What % total is that? I keep reading about the big boys buying them out but I am under the impression that MMJ (just purchased Dosecann - partners with EMC on special delivery methods) is going to grow this out. Wouldnt the offer need to be very stong considering they have Two products in Clincal Trials phase 2 (epilepsy and MS) two more in Clinical trial phase 1? The product Satipharm is now waiting for HC approval on their other products, should get approval in Q1 2018. I would love to see the sales of the GEL Pell after Q2 this year..